Literature DB >> 15989415

Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing.

Sarah Braunstein1, Janneke van de Wijgert.   

Abstract

BACKGROUND: Research on vaginal microbicides for HIV prevention is progressing rapidly; the first large-scale effectiveness trials were launched in 2004. The majority of candidate microbicides are formulated as gels, which will act as lubricants when used during sex. Preferences and practices regarding lubrication during sex, therefore, likely influence microbicide acceptability and use. Researchers seek to maximize consistent and correct use of candidate microbicides during clinical trials to enable valid estimates of product effectiveness, and if proven effective, microbicides will be widely used only if acceptable.
METHODS: We conducted a comprehensive literature review and interviewed 13 key informants from nine countries in Africa, Asia, Latin America, and North America.
RESULTS: We found that norms and practices regarding lubrication during sex exist in many different countries. Despite significant variation, common themes emerged. In the majority of countries, women's genital hygiene is highly valued, and women are expected to achieve a moderate amount of vaginal lubrication during sex that is neither excessive nor inadequate. Women may try to achieve this by engaging in a wide variety of vaginal practices.
CONCLUSIONS: Even though some informants expressed concerns about the acceptability of lubricating microbicides in some settings, they thought that microbicides should be developed, that women and men may be willing to accept a certain level of increased lubrication in exchange for protection from HIV, and that lubricating microbicides may be considered more acceptable when perceived as genital hygiene products. Recommendations are made on how to take vaginal practices into account during clinical testing of microbicides.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15989415     DOI: 10.1089/jwh.2005.14.424

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  37 in total

1.  Achieving the optimal vaginal state: using vaginal products and study gels in Uganda, Zimbabwe, and South Africa.

Authors:  Zoe Duby; Barbara Mensch; Miriam Hartmann; Elizabeth Montgomery; Imelda Mahaka; Linda-Gail Bekker; Ariane van der Straten
Journal:  Int J Sex Health       Date:  2017-03-27

2.  Quantitative perceptual differences among over-the-counter vaginal products using a standardized methodology: implications for microbicide development.

Authors:  Ellen D Mahan; Kathleen M Morrow; John E Hayes
Journal:  Contraception       Date:  2011-01-07       Impact factor: 3.375

3.  Vaginal practices, microbicides and HIV: what do we need to know?

Authors:  A Martin Hilber; M F Chersich; J H H M van de Wijgert; H Rees; M Temmerman
Journal:  Sex Transm Infect       Date:  2007-12       Impact factor: 3.519

Review 4.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

5.  Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.

Authors:  Toral Zaveri; Cordelia A Running; Lahari Surapaneni; Gregory R Ziegler; John E Hayes
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

6.  Intravaginal cleansing among women attending a sexually transmitted infection clinic in Kingston, Jamaica.

Authors:  M Carter; M Gallo; C Anderson; M C Snead; J Wiener; A Bailey; E Costenbader; J Legardy-Williams; T Hylton-Kong
Journal:  West Indian Med J       Date:  2013-01       Impact factor: 0.171

7.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.

Authors:  Kari Bo; Helena C Frawley; Bernard T Haylen; Yoram Abramov; Fernando G Almeida; Bary Berghmans; Maria Bortolini; Chantale Dumoulin; Mario Gomes; Doreen McClurg; Jane Meijlink; Elizabeth Shelly; Emanuel Trabuco; Carolina Walker; Amanda Wells
Journal:  Int Urogynecol J       Date:  2016-12-05       Impact factor: 2.894

8.  Vaginal practices of HIV-negative Zimbabwean women.

Authors:  Abigail Norris Turner; Charles S Morrison; Marshall W Munjoma; Precious Moyo; Tsungai Chipato; Janneke H van de Wijgert
Journal:  Infect Dis Obstet Gynecol       Date:  2010-08-24

9.  Health practices and vaginal microbicide acceptability among urban black women.

Authors:  Marian Reiff; Christine Wade; Maria T Chao; Fredi Kronenberg; Linda F Cushman
Journal:  J Womens Health (Larchmt)       Date:  2008-10       Impact factor: 2.681

10.  Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men.

Authors:  Ana Ventuneac; Alex Carballo-Diéguez; Ian McGowan; Robert Dennis; Amy Adler; Elena Khanukhova; Charles Price; Terry Saunders; Chomchay Siboliban; Peter Anton
Journal:  AIDS Behav       Date:  2009-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.